
Charles Miller Fisher
Charles Miller Fisher (1913 - 2012) was a Canadian neurologist. Miller Fisher syndrome (1956) an acquired nerve disease variant of Guillain-Barré syndrome.

Charles Miller Fisher (1913 - 2012) was a Canadian neurologist. Miller Fisher syndrome (1956) an acquired nerve disease variant of Guillain-Barré syndrome.

Visceral artery aneurysm (VAA) and visceral artery pseudoaneurysm (VAPA) are arterial aneurysms affecting the coeliac, superior mesenteric, or inferior mesenteric arteries and their branches.

Henri Parinaud (1844-1905) was a French ophthalmologist and neurologist. Parinaud Syndrome (1883) aka Dorsal Midbrain Syndrome

Charles S. Hallpike (1900–1979), British neuro-otologist, co-devised the Dix–Hallpike manoeuvre, clarified Menière’s disease pathology, and pioneered vestibular physiology.

Asthma is a chronic disease with acute, potentially fatal exacerbations. ED care hinges on severity assessment, rapid bronchodilation, and appropriate escalation.

Aspiration can cause chemical pneumonitis or bacterial pneumonia; management depends on severity and suspicion of infection, with antibiotics if in doubt.

Axillary and subclavian vein thrombosis is an important diagnosis to make. The incidence of pulmonary embolism (PE) and long-term sequelae is high in untreated cases.

Asbestosis is a progressive fibrotic lung disease from asbestos inhalation, with restrictive pattern, pleural disease, and risk of mesothelioma and lung cancer.

André Strohl (1887-1977) was a French physician and physicist. Guillain-Barré-Strohl syndrome described in 1916

Pleural effusion is fluid accumulation in the pleural space, classified as transudate or exudate. Diagnosis is clinical and radiological; aspiration guides cause and therapy.

Michael Leo Leventhal (1901-1971) was an American gyecologist. Leventhal is remembered for his contribution to the field of infertility and eponymously for the Stein–Leventhal Syndrome (1934)

Nasal High Flow oxygen delivers humidified, warmed high-flow oxygen via nasal cannula, providing a well-tolerated alternative to NIV in mild to moderate respiratory distress.